126 related articles for article (PubMed ID: 12708491)
1. Histological characteristics of tumors in blood vessels play an important role in tumor progression of invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Cancer Sci; 2003 Feb; 94(2):158-65. PubMed ID: 12708491
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Mod Pathol; 2002 Sep; 15(9):904-13. PubMed ID: 12218207
[TBL] [Abstract][Full Text] [Related]
3. Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Cancer Sci; 2003 Feb; 94(2):181-7. PubMed ID: 12708494
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Virchows Arch; 2004 Jan; 444(1):20-7. PubMed ID: 14624360
[TBL] [Abstract][Full Text] [Related]
5. Histological characteristics of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Hum Pathol; 2004 Mar; 35(3):298-308. PubMed ID: 15017585
[TBL] [Abstract][Full Text] [Related]
6. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Sasaki S; Mukai K
Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
[TBL] [Abstract][Full Text] [Related]
7. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
8. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
[TBL] [Abstract][Full Text] [Related]
9. Tumor cells in lymph vessels and lymph nodes closely associated with nodal metastasis by invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Cancer Sci; 2003 Jun; 94(6):508-14. PubMed ID: 12824875
[TBL] [Abstract][Full Text] [Related]
10. Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.
Hasebe T; Tamura N; Iwasaki M; Okada N; Akashi-Tanaka S; Hojo T; Shimizu C; Adachi M; Fujiwara Y; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
Mod Pathol; 2010 Apr; 23(4):581-92. PubMed ID: 20118911
[TBL] [Abstract][Full Text] [Related]
11. Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.
Hasebe T; Iwasaki M; Hojo T; Shibata T; Kinoshita T; Tsuda H
Cancer Sci; 2013 Sep; 104(9):1252-61. PubMed ID: 23758085
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Am J Pathol; 2000 May; 156(5):1701-10. PubMed ID: 10793081
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
Yue M; Li F; Deng HY; Zhang LL; Liu YP
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
[No Abstract] [Full Text] [Related]
15. Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Wada N; Ishii G; Ochiai A
Br J Cancer; 2005 Mar; 92(5):847-56. PubMed ID: 15756255
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular infiltration in the tumor bed is a useful marker of biological behavior in breast cancer.
Panagiotopoulos N; Lagoudianakis E; Pappas A; Filis K; Salemis N; Manouras A; Kontzoglou K; Zografos G
J BUON; 2016; 21(5):1082-1089. PubMed ID: 27837608
[TBL] [Abstract][Full Text] [Related]
17. Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.
Hasebe T; Konishi M; Iwasaki M; Endoh Y; Nakagohri T; Takahashi S; Kinoshita T; Ochiai A
Hum Pathol; 2005 Jun; 36(6):655-64. PubMed ID: 16021572
[TBL] [Abstract][Full Text] [Related]
18. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
[TBL] [Abstract][Full Text] [Related]
19. Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy.
Tamura N; Hasebe T; Okada N; Houjoh T; Akashi-Tanaka S; Shimizu C; Shibata T; Sasajima Y; Iwasaki M; Kinoshita T
Cancer Sci; 2009 Oct; 100(10):1823-33. PubMed ID: 19604245
[TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
